• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·UK·Healthcare·ANCR.L
Share

Animalcare Group plc Stocks

£ 335Last Updated 30.07.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

£ 312.95M

£ 335
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Animalcare Group plc specializes in the research, commercialization, and supply of licensed veterinary medicines and animal identification solutions. These products and services are developed for pets, livestock, and horses, serving their respective veterinary markets. The company also engages in the wholesale distribution and promotion of these specialized animal pharmaceuticals. With a broad international footprint, Animalcare Group plc caters to customers across Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, and Africa. Established in 1972, its operations are headquartered in York, United Kingdom.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of ANCR.L is 336 and suggests 0.299% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendat

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 15:28

Morning in New York: A New Stress Test for the AI Rally

09.10.2026 15:17

With AI, it's possible to develop a drug twice as fast. Which companies is Cathie Wood betting on?

09.10.2026 15:00

TRex Bio IPO: Shares of Eli Lilly's Partner Pharmaceutical Company Are Now Available

09.10.2026 14:39

European telecom stocks plummeted following the U.S. market: SpaceX is entering the mobile carrier market

09.10.2026 13:23

What makes Physical Intelligence—the company Bezos has invested in—so interesting?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026